Screening for coronary artery disease in patients with type 2 diabetes did not result in a significant reduction in the rate of heart attacks or cardiac death compared to patients who were not screened, according to a study in the April 15 issue of JAMA, a theme issue on diabetes.
Frans J. Th. Wackers, M.D., Ph.D., of the Yale University School of Medicine, New Haven, Conn., presented the findings of the study at a JAMA media briefing at the National Press Club in Washington, D.C.